home · filing · 0001047127-23-000045
8-K
filed December 15, 2023, 6:59 PM ET
ticker AMKR
CIK 0001047127
leadership
confidence high
sentiment neutral
materiality 0.50
Amkor EVP Worldwide Manufacturing Steve Shin departs; JinAn Lee named successor
AMKOR TECHNOLOGY, INC.
Sung (Steve) Shin to leave Amkor on December 15, 2023; JinAn Lee to lead manufacturing effective same date.
Shin entered a separation agreement with Amkor Technology Korea, Inc., receiving KRW 441.7M (~USD 342,000) lump sum.
Separation includes accrued salary, unused vacation, and equity treatment per award agreements; confidentiality and non-compete provisions apply.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
JinAn Lee
Other Named Officer
AMKR ·
AMKOR TECHNOLOGY, INC.
Effective 2023-12-15
Filed December 15, 2023, 6:59 PM ET
JinAn Lee will lead manufacturing starting December 15, 2023
Effective 2023-12-15
Successor JinAn Lee
Filed December 15, 2023, 6:59 PM ET
Sung (Steve) Shin, Executive Vice President, Worldwide Manufacturing, will leave Amkor on December 15, 2023
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
JinAn Lee was appointed as other_named_officer at AMKOR TECHNOLOGY, INC..
Action will lead manufacturing
Exact text from the filing
JinAn Lee will lead manufacturing starting December 15, 2023
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Sung (Steve) Shin departed as Executive Vice President, Worldwide Manufacturing at AMKOR TECHNOLOGY, INC..
Action will leave
Role Executive Vice President, Worldwide Manufacturing
Exact text from the filing
Sung (Steve) Shin, Executive Vice President, Worldwide Manufacturing, will leave Amkor on December 15, 2023
View on SEC.gov
Source: SEC EDGAR
accession 0001047127-23-000045
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.